If you live in the Dallas metro area and received a Stryker hip implant as part of a hip replacement surgery, you should be aware that according to the U.S. Food and Drug Administration (FDA), has voluntarily recalled its Rejuvenate and ABG II modular-neck stems in July 2012.
Stuart Simpson, Vice President and General Manager, Hip Reconstruction for Stryker is quoted:
“While modular-neck stems provide surgeons with an option to correct certain aspects of a patient’s anatomy and hip biomechanics, given the potential risks associated with fretting and corrosion at the modular neck junction, Stryker Orthopaedics decided to take this voluntary action…”Following this action, we will work with the medical community to better understand this matter as we continue to evaluate the data.”
Stryker also notified healthcare professionals and regulatory bodies of the voluntary recall, and has set up a patient call center. Recipients of Stryker Rejuvenate and ABG II modular-neck stem hip implants can call 1-888-317-0200 and additional information can be found at www.AboutStryker.com/ModularNeckStems.
Patients who received a Rejuvenate Modular or ABG II modular-neck stem are encouraged to contact their surgeon. Patients uncertain if they have one of these products implanted should contact their surgeon or consult their medical records.
The issue with the Stryker implants included in the recall is their ability to degrade over time and release potentially toxic levels of cobalt, chromium and titanium in the system of the recipient.